Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288077427> ?p ?o ?g. }
- W4288077427 abstract "Abstract Background There is limited information regarding disease-modifying antirheumatic drug (DMARD)-dependent risks of overall, incident, and recurrent herpes zoster (HZ) during first-line biologic DMARD (bDMARD) or targeted synthetic DMARD (tsDMARD) treatment among patients with seropositive rheumatoid arthritis (RA) in terms of HZ risk. Methods A total of 11,720 patients with seropositive RA who were prescribed bDMARD or tofacitinib between January 2011 and January 2019 from the Korean Health Insurance Review & Assessment Service database were studied. A multivariate Cox proportional hazards regression model was adopted to evaluate the adjusted hazard ratio (aHR) with 95% confidence interval (CI) for the risk of HZ dependent on the choice of first-line bDMARDs or tsDMARD, including etanercept, infliximab, adalimumab, golimumab, tocilizumab, rituximab, tofacitinib, and abatacept. Results During the 34,702 person-years of follow-up, 1686 cases (14.4%) of HZ were identified, including 1372 (11.7%) incident and 314 (2.7%) recurrent HZs. Compared with that of the abatacept group, tofacitinib increased the overall risk (aHR, 2.46; 95% CI, 1.61–3.76; P <0.001), incidence (aHR, 1.99; 95% CI, 1.18–3.37; P =0.011), and recurrence (aHR, 3.69; 95% CI, 1.77–7.69; P <0.001) of HZ. Infliximab (aHR, 1.36; 95% CI, 1.06–1.74; P =0.017) and adalimumab (aHR, 1.29; 95% CI, 1.02–1.64; P =0.032) also increased the overall HZ risk. Moreover, a history of HZ was found to be an independent risk factor for HZ (aHR, 1.54; 95% CI, 1.33–1.78; P <0.001). Conclusions HZ risk is significantly increased in RA patients with a history of HZ after the initiation of bDMARDs or tsDMARD. The risk of incident and recurrent HZ was higher after tofacitinib treatment in patients with RA than that after treatment with bDMARDs. Individualized characteristics and history of HZ should be considered when selecting bDMARDs or tsDMARD for RA patients considering HZ risks." @default.
- W4288077427 created "2022-07-28" @default.
- W4288077427 creator A5005726505 @default.
- W4288077427 creator A5035047849 @default.
- W4288077427 creator A5051694555 @default.
- W4288077427 creator A5073849154 @default.
- W4288077427 creator A5075542913 @default.
- W4288077427 creator A5077527676 @default.
- W4288077427 date "2022-07-28" @default.
- W4288077427 modified "2023-10-04" @default.
- W4288077427 title "Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study" @default.
- W4288077427 cites W1565555821 @default.
- W4288077427 cites W1835690873 @default.
- W4288077427 cites W1991831820 @default.
- W4288077427 cites W2032188830 @default.
- W4288077427 cites W2040331803 @default.
- W4288077427 cites W2048677706 @default.
- W4288077427 cites W2075994714 @default.
- W4288077427 cites W2086560514 @default.
- W4288077427 cites W2091055562 @default.
- W4288077427 cites W2095522674 @default.
- W4288077427 cites W2112219502 @default.
- W4288077427 cites W2117215550 @default.
- W4288077427 cites W2120393706 @default.
- W4288077427 cites W2132828342 @default.
- W4288077427 cites W2142004396 @default.
- W4288077427 cites W2297608701 @default.
- W4288077427 cites W2343866616 @default.
- W4288077427 cites W2532019520 @default.
- W4288077427 cites W2544991555 @default.
- W4288077427 cites W2559774515 @default.
- W4288077427 cites W2592210645 @default.
- W4288077427 cites W2734125076 @default.
- W4288077427 cites W2800826112 @default.
- W4288077427 cites W2801185219 @default.
- W4288077427 cites W2801505484 @default.
- W4288077427 cites W2899542141 @default.
- W4288077427 cites W2906648684 @default.
- W4288077427 cites W2937092216 @default.
- W4288077427 cites W2972593257 @default.
- W4288077427 cites W3005067674 @default.
- W4288077427 cites W3027653883 @default.
- W4288077427 cites W3036590284 @default.
- W4288077427 cites W3171218682 @default.
- W4288077427 cites W4239943677 @default.
- W4288077427 cites W4246780304 @default.
- W4288077427 doi "https://doi.org/10.1186/s13075-022-02871-1" @default.
- W4288077427 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35902964" @default.
- W4288077427 hasPublicationYear "2022" @default.
- W4288077427 type Work @default.
- W4288077427 citedByCount "3" @default.
- W4288077427 countsByYear W42880774272023 @default.
- W4288077427 crossrefType "journal-article" @default.
- W4288077427 hasAuthorship W4288077427A5005726505 @default.
- W4288077427 hasAuthorship W4288077427A5035047849 @default.
- W4288077427 hasAuthorship W4288077427A5051694555 @default.
- W4288077427 hasAuthorship W4288077427A5073849154 @default.
- W4288077427 hasAuthorship W4288077427A5075542913 @default.
- W4288077427 hasAuthorship W4288077427A5077527676 @default.
- W4288077427 hasBestOaLocation W42880774271 @default.
- W4288077427 hasConcept C126322002 @default.
- W4288077427 hasConcept C207103383 @default.
- W4288077427 hasConcept C2777138892 @default.
- W4288077427 hasConcept C2777178219 @default.
- W4288077427 hasConcept C2777226972 @default.
- W4288077427 hasConcept C2777575956 @default.
- W4288077427 hasConcept C2778886723 @default.
- W4288077427 hasConcept C2779134260 @default.
- W4288077427 hasConcept C2779338263 @default.
- W4288077427 hasConcept C2779605438 @default.
- W4288077427 hasConcept C2780132546 @default.
- W4288077427 hasConcept C2780653079 @default.
- W4288077427 hasConcept C2781290027 @default.
- W4288077427 hasConcept C44249647 @default.
- W4288077427 hasConcept C50382708 @default.
- W4288077427 hasConcept C71924100 @default.
- W4288077427 hasConcept C72563966 @default.
- W4288077427 hasConceptScore W4288077427C126322002 @default.
- W4288077427 hasConceptScore W4288077427C207103383 @default.
- W4288077427 hasConceptScore W4288077427C2777138892 @default.
- W4288077427 hasConceptScore W4288077427C2777178219 @default.
- W4288077427 hasConceptScore W4288077427C2777226972 @default.
- W4288077427 hasConceptScore W4288077427C2777575956 @default.
- W4288077427 hasConceptScore W4288077427C2778886723 @default.
- W4288077427 hasConceptScore W4288077427C2779134260 @default.
- W4288077427 hasConceptScore W4288077427C2779338263 @default.
- W4288077427 hasConceptScore W4288077427C2779605438 @default.
- W4288077427 hasConceptScore W4288077427C2780132546 @default.
- W4288077427 hasConceptScore W4288077427C2780653079 @default.
- W4288077427 hasConceptScore W4288077427C2781290027 @default.
- W4288077427 hasConceptScore W4288077427C44249647 @default.
- W4288077427 hasConceptScore W4288077427C50382708 @default.
- W4288077427 hasConceptScore W4288077427C71924100 @default.
- W4288077427 hasConceptScore W4288077427C72563966 @default.
- W4288077427 hasFunder F4320322107 @default.
- W4288077427 hasIssue "1" @default.
- W4288077427 hasLocation W42880774271 @default.
- W4288077427 hasLocation W42880774272 @default.
- W4288077427 hasLocation W42880774273 @default.
- W4288077427 hasOpenAccess W4288077427 @default.